Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
---|---|
State: | Georgia |
Type of Government: | Federal |
Category: |
|
Posted: | Apr 17, 2024 |
Due: | Apr 26, 2024 |
Solicitation No: | 000HCKBG-2024-84795 |
Publication URL: | To access bid details, please log in. |
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
NOTICE OF INTENT TO ISSUE AN ORDER. This is not a request for competitive proposals/quotes. The Centers for Disease Control and Prevention (CDC) hereby announces its intent to issue a sole source order to NanoComposix, Inc. 4878 Ronson Ct., Suite J San Diego, CA for of the procurement of Nanocomposix Lateral flow assay design using antibodies developed by the CDC to detect antiretroviral drugs
The NAICS code for this acquisition is 541713 Research And Development In Nanotechnology
*****
Subject to the Availability of Funds
*****
Nanocomposix Lateral flow assay design using antibodies developed by the CDC to detect antiretroviral drugs
*****
A determination by the Government not to compete this proposed action will be based on responses to this notice and is solely in the discretion of the Contracting Officer. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.
All vendors must be registered in the System for Award Management (SAM) at www.sam.gov , prior to an award of a federal contract.
This action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit quotations.
This is not a request for competitive quotations; however, the Government will review any/all product, capabilities, and pricing information submitted prior to the closure of this notice. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.
Responsible sources that believe they possess the expertise and capabilities identified above are hereby afforded the opportunity to submit to the Contracting Officer by the due date of this notice, their written capabilities statement and pricing information in the format they choose, not to exceed 10 pages. Please forward, as applicable, any capabilities, product, pricing information (for products, etc.), and/or other pertinent information to kpz6@cdc.gov.
Any responses should be emailed to kpz6@cdc.gov by April 26, 2024 at 12:00 PM. EST.
Apr 22, 2024 | [Presolicitation (Updated)] Notice of Intent to Sole Source - Lateral flow assay design using antibodies developed by the CDC to detect antiretroviral drugs |
With GovernmentContracts, you can:
Follow Request for Information (RFI) Active Contract Opportunity Notice ID AFCEC24R0002 Related Notice
Federal Agency
Bid Due: 6/08/2024
Follow USACE National Dredging Meeting, 5-6 June 2024 Active Contract Opportunity Notice ID
Federal Agency
Bid Due: 5/10/2024
Event Details Event ID Event Type Event Status Purchase Type Category Type Government
State Government of Georgia
Bid Due: 5/08/2024
Event Details Event ID Event Type Event Status Purchase Type Category Type Government
State Government of Georgia
Bid Due: 5/06/2024